Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cellsEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92023-12-017PRE
Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38a kinase inhibitory activity: Synthesis, in vitro assays and in silico studyEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72022-04-0114OA
Discovery of New Imidazo[2,1-b]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma ActivityJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-05-1726OAAI
Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAFV600E/p38α inhibitorsEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92021-04-0121OAAI
Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitorBIOORGANIC & MEDICINAL CHEMISTRYIF32021-02-0130OAAI
Design and synthesis of novel pyrrolo[2,3-b]pyridine derivatives targeting V600EBRAFBIOORGANIC & MEDICINAL CHEMISTRYIF32020-06-0117PREAI